Search
for
Sort by
Research 61–90 of 351
- Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil
- Role of Oxidative Stress in Obese and Nonobese PCOS Patients
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- Hair and cord blood element levels and their relationship with air pollution, dietary intake, gestational diabetes mellitus, and infant neurodevelopment
- Complex X chromosome rearrangement associated with multiorgan autoimmunity
- Eating Disorders and Diabetes: Facing the Dual Challenge
- Comparison of In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycle Outcome in Patients with and without Polycystic Ovary Syndrome: A Modified Poisson Regression Model.
- Characteristics of pregnancy with Systemic Lupus Erythematosus (SLE) in Dr. Mohammad Hoesin Hospital, Palembang
- Polycystic Ovary Syndrome in Adolescents
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Covid-19 in Lupus Nephritis
- Mini Review on Polycystic Ovary Syndrome (PCOS)
- Polycystic ovarian syndrome
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Polycystic Ovary Syndrome
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013
- Skin disease in pregnancy
- Dermatoses of pregnancy
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- PCOS and Obesity: Contraception Challenges
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Fertility problems in women with polycystic ovary syndrome
- Dermatoses of pregnancy
- Clinical manifestations of polycystic ovary syndrome